Company: NCEL
Filing Date: 2025-10-24
Form Type: POS AM
Source: 0001213900-25-102149
Chunk: 27

Company: NewcelX Ltd.
Filing Date: 2025-10-24
Form: POS AM
Chunk 27
---
 some or none of such shares at any time or from time-to-time in its discretion and at different prices. As a result, investors
who purchase shares from the Selling Shareholder in this offering at different times will likely pay different prices for those shares,
and so may experience different levels of dilution and in some cases substantial dilution and different outcomes in their investment results.
Investors may experience a decline in the value of the shares they purchase from the Selling Shareholder in this offering as a result
of future sales made by us to the Selling Shareholder at prices lower than the prices such investors paid for their shares in this offering.

We may require additional financing to sustain our operations and without it we will not be able to continue operations.

The extent to which we rely
on the Selling Shareholder as a source of funding will depend on a number of factors, including the prevailing market price of our Common
Shares, our ability to meet the conditions necessary to deliver advance notices under the Purchase Agreement and the extent to which we
are able to secure funding from other sources. Regardless of the amount of funds we ultimately raise under the Purchase Agreement, if
any, we expect to continue to seek other sources of funding. Even if we were to sell to the Selling Shareholder the total commitment of
$25.0 million, of which to date we have not sold any Common Shares (other than the Commitment Shares), under the Purchase Agreement we
will still need additional capital to fully implement our business plan.

Future sales and issuances of our Common Shares or other securities might result in significant dilution and could cause the price of our Common Shares to decline.

To raise capital, we may sell
Common Shares, convertible securities or other equity securities in one or more transactions other than those contemplated by the Purchase
Agreement, at prices and in a manner we determine from time-to-time. We may sell shares or other securities in any other offering at a
price per share that is less than the price per share paid by investors in this offering, and investors purchasing shares or other securities
in the future could have rights superior to existing stockholders. The price per share at which we sell additional Common Shares, or securities
convertible or exchangeable into Common Shares, in future transactions may be higher or lower than the price per share paid by investors
in this offering. Any sales of additional shares will dilute our stockholders.

Sales of a substantial number
of Common Shares in the public market or the perception that these sales might occur could depress